The National Trial Lawyers
  • Home
    • Meet Our Team
    • Contact Us
    • Mission & Goals
    • FAQ
  • Webinars
  • News
  • Membership Directory
    • Top 100 Map – Civil Plaintiff
    • Top 100 Map – Criminal Defense
    • Top 40 Under 40 Map – Civil Plaintiff
    • Top 40 Under 40 Map – Criminal Defense
  • Top 100
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Benefits
    • About
    • Top 100 President’s Message
    • Diplomat
    • Membership Renewal
    • Member Profile Updates
    • Top 100 Badge
    • Media
  • Top 40
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Top 40 Under 40 Trial Academy Bootcamp
    • Benefits
    • About
    • Top 40 President’s Message
    • Membership Renewal
    • Member Profile Updates
    • Top 40 Badge
    • Media
  • Specialty Assoc
    • About
    • Shop
    • Officers
    • Membership Renewal
    • Member Profile Updates
    • Media
  • Nominate
    • Top 100
    • Top 40
    • Specialty Association
    • Trial Lawyer Hall of Fame
    • Trial Lawyer of the Year
    • Trial Team of the Year
    • America’s Most Influential Trial Lawyer
    • America’s Most Influential Law Firm
    • Lifetime Achievement Award
  • Shop
  • Magazine
    • A-List
  • Education and Networking Agenda
    • Trial Lawyers Summit
      • Summit Sponsors
    • Top 40 Under 40 Trial Academy Boot Camp
    • Mass Torts Made Perfect
    • The Lanier Master Class 5.0 Trial Academy 2021
    • Webinars
  • Hall of Fame
    • Trial Lawyer Hall of Fame

$97M Settlement Between Gilead and DOJ Over Kickbacks

Posted on September 25, 2020 by The National Trial Lawyers

Amid an industrywide kickbacks investigation into pharma’s charity contributions, Gilead Sciences has become the latest drugmaker to strike a deal. Though the company says it doesn’t believe it violated any laws, it agreed to pay $97 million to resolve kickbacks allegations.

Gilead inked the settlement with the Department of Justice (DOJ) to resolve claims it used a patient foundation as a “conduit” to cover Medicare patients’ copays for Letairis, a pulmonary arterial hypertension drug that’s now off patent.

Gilead is the latest drugmaker to strike a deal in the yearslong probe, following settlements of various sizes for Sanofi, Pfizer, Astellas, Amgen, Alexion and United Therapeutics, among others. 

Read the source article at Pharma News

Posted in Civil Plaintiff

Comments are closed.

Recent Posts

Texas and Johnson & Johnson Reach a $290 Million Opioid Settlement

Texas and Johnson & Johnson Reach a $290 Million Opioid Settlement

October 27th, 2021

Texas Attorney General Ken Paxton announced a $290 million settlement agreement Tuesday with pharmaceutical giant J[Read More...]
Luckin Coffee Agrees to a $175 Million Class Action Settlement Over Claims of Accounting Fraud

Luckin Coffee Agrees to a $175 Million Class Action Settlement Over Claims of Accounting Fraud

October 27th, 2021

Luckin Coffee Inc (LC0Ay.MU), reached a $175 million settlement of shareholder class-action claims that the Chinese riva[Read More...]
What You Need to Know About Dangerous Drugs & Devices

What You Need to Know About Dangerous Drugs & Devices

October 26th, 2021

Numerous Americans seek medical attention to help reduce their pain and suffering and improve their quality of life. Pre[Read More...]
A Judge Denies Robert De Niro's Estranged Wife's Request for a $500 Million Divorce Settlement

A Judge Denies Robert De Niro's Estranged Wife's Request for a $500 Million Divorce Settlement

October 25th, 2021

Robert De Niro won’t have to shell out a ton of cash to his estranged wife Grace Hightower in their ongoing d[Read More...]
An $8.6 Million Pollution Settlement Is Helping an Illinois Town Fund Solar Panels

An $8.6 Million Pollution Settlement Is Helping an Illinois Town Fund Solar Panels

October 25th, 2021

Years of pollution from the coal-fired Edwards Power Plant in Bartonville are helping produce a[Read More...]

Contact Us | Terms of Use | Privacy Policy

Attorney information and content provided on this website is provided for the benefit of members of The National Trial Lawyers and as a public service by Legal Associations Management, Inc. The website and all data are the property of Legal Associations Management, Inc. Data, including without limitation attorney information and content, on the site may not be mined, sold, or used commercially for any purpose without the explicit written consent of Legal Associations Management, Inc. This site may not be accessed by any automated program for extracting data for any use. By accessing and using the site you agree that you will not develop, support or use software, devices, scripts, robots, or any other means or processes (including crawlers, browser plug-ins and add-ons, or any other technology) to scrape data or otherwise copy profiles and other data. Unauthorized use or attempted unauthorized use of this system may subject you to both civil and criminal penalties.